Ownership

Urte Gayko

Insider Reports History

Entity: Individual
Location: C/O Parmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA
Signature: /s/ Urte Gayko
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Urte Gayko:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Summit Therapeutics Inc.	Director	Stock Option (right to buy)	400K	$528K	$1.32	Apr 25, 2022	Direct

Showing 1 to 1 of 1 entries

Insider Reports Filed by Urte Gayko

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SMMT	Summit Therapeutics Inc.	Apr 25, 2022	1	$0	4	Apr 26, 2022	Director
SMMT	Summit Therapeutics Inc.	Jan 3, 2022	2	$48.1K	4	Jan 5, 2022	Director
SMMT	Summit Therapeutics Inc.	Nov 3, 2021	2	$0	4	Nov 16, 2021	Director
SMMT	Summit Therapeutics Inc.	Nov 3, 2021	0	$0	3	Nov 16, 2021	Director